With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

Michelle Xia represents a rising generation of biotech companies in China challenging Western giants.

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

A federal commission is calling for $15 billion in new financing to re-enforce the United States’ biotech leadership amid ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and ...

Moleculin Biotech has begun dosing subjects in a Phase III trial of Annamycin with Cytarabine for treating acute myeloid ...